Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > looks like TD is done screwing around

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon Nov 08, 2024 12:27pm

143 Views

Post# 36303447

RE:RE:looks like TD is done screwing around

As for "meeting guidance", I look at this next event as a do-or-die moment.
If they fail again, I will be taking my substantial position and moving on to greener pastures.
Because if they fail again, how can we not consider them to be nothing more than outright liars?

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project